AP NEWS

Adma Biologics: 2Q Earnings Snapshot

August 10, 2018

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Friday reported a loss of $14.7 million in its second quarter.

On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 35 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The infectious disease drug developer posted revenue of $4.7 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $5.4 million.

Adma Biologics shares have increased 96 percent since the beginning of the year. The stock has more than doubled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

AP RADIO
Update hourly